![Jeffrey Allen Ferrell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Allen Ferrell
Direktor/Vorstandsmitglied bei
BIORA THERAPEUTICS, INC.
Profil
Mr. Jeffrey A. Ferrell is an Independent Director at Biora Therapeutics, Inc. and a Managing Partner at Athyrium Capital Management LP.
He is on the Board of Directors at Biora Therapeutics, Inc. and Secura Bio, Inc. He has over 25 years of investment experience in the life sciences sector across both public and private markets across a wide range of transaction structures.
He is a member of the firm’s Investment Committee.
Mr. Ferrell was previously employed as an Independent Director by Lpath, Inc., a Vice President & Principal by Lehman Brothers, Inc., and a Principal by SV Life Sciences Advisers LLC.
He also served on the board at Minrad International, Inc.
He received his A.B. in Biochemical Sciences from Harvard College.
Aktive Positionen von Jeffrey Allen Ferrell
| Unternehmen | Position | Beginn |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.06.2014 |
Athyrium Capital Management LP
 Athyrium Capital Management LP Investment ManagersFinance Athyrium specializes in the healthcare sector and is primarily focused on longer-term investments including private equity, public equity and structured investments. Structured investments are investments composed of one or more of the following instruments: convertibles, loans, bonds, preferred stock, common stock, warrants, and royalties. The firm most typically employs a fundamental buy and hold strategy. Their approach to analysis is typically private equity-like in nature and includes sourcing, due diligence, structuring and negotiating transactions, and actively monitoring portfolio investments. | Vorstandsvorsitzender | 09.12.2008 |
Secura Bio, Inc.
 Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jeffrey Allen Ferrell
| Unternehmen | Position | Ende |
|---|---|---|
Lpath, Inc.
 Lpath, Inc. BiotechnologyHealth Technology Discovers and develops lipidomic-based therapeutic antibodies | Direktor/Vorstandsmitglied | 01.01.2016 |
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Private Equity Investor | 01.11.2008 |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Corporate Officer/Principal | - |
Minrad International, Inc.
 Minrad International, Inc. Pharmaceuticals: MajorHealth Technology Develops generic inhalation anesthetics | Direktor/Vorstandsmitglied | 02.03.2009 |
Ausbildung von Jeffrey Allen Ferrell
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is an active manager. | Finance |
Minrad International, Inc.
Minrad International, Inc. Pharmaceuticals: MajorHealth Technology Develops generic inhalation anesthetics | Health Technology |
Lpath, Inc.
Lpath, Inc. BiotechnologyHealth Technology Discovers and develops lipidomic-based therapeutic antibodies | Health Technology |
Athyrium Capital Management LP
Athyrium Capital Management LP Investment ManagersFinance Athyrium specializes in the healthcare sector and is primarily focused on longer-term investments including private equity, public equity and structured investments. Structured investments are investments composed of one or more of the following instruments: convertibles, loans, bonds, preferred stock, common stock, warrants, and royalties. The firm most typically employs a fundamental buy and hold strategy. Their approach to analysis is typically private equity-like in nature and includes sourcing, due diligence, structuring and negotiating transactions, and actively monitoring portfolio investments. | Finance |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
Secura Bio, Inc.
Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Health Technology |
